Duncker Streett & Co’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-839
Closed -$32K – 501
2021
Q1
$32K Hold
839
– – 0.01% 371
2020
Q4
$30K Hold
839
– – 0.01% 375
2020
Q3
$32K Hold
839
– – 0.01% 353
2020
Q2
$29K Hold
839
– – 0.01% 355
2020
Q1
$27K Hold
839
– – 0.01% 365
2019
Q4
$38K Buy
+839
New +$35.1K 0.01% 371
2019
Q3
– Sell
-839
Closed -$36K – 289
2019
Q2
$36K Hold
839
– – 0.01% 392
2019
Q1
$32K Hold
839
– – 0.01% 411
2018
Q4
$30K Hold
839
– – 0.01% 399
2018
Q3
$32K Hold
839
– – 0.01% 424
2018
Q2
$27K Hold
839
– – 0.01% 437
2018
Q1
$23K Hold
839
– – 0.01% 452
2017
Q4
$21K Hold
839
– – 0.01% 463
2017
Q3
$24K Hold
839
– – 0.01% 446
2017
Q2
$23K Hold
839
– – 0.01% 450
2017
Q1
$21K Hold
839
– – 0.01% 470
2016
Q4
$18K Hold
839
– – 0.01% 477
2016
Q3
$20K Hold
839
– – 0.01% 450
2016
Q2
$20K Hold
839
– – 0.01% 443
2016
Q1
$16K Hold
839
– – 0.01% 467
2015
Q4
$15K Hold
839
– – 0.01% 478
2015
Q3
$14K Hold
839
– – 0.01% 483
2015
Q2
$15K Hold
839
– – 0.01% 489
2015
Q1
$15K Hold
839
– – ﹤0.01% 492
2014
Q4
$11K Hold
839
– – ﹤0.01% 514
2014
Q3
$10K Hold
839
– – ﹤0.01% 520
2014
Q2
$11K Hold
839
– – ﹤0.01% 513
2014
Q1
$11K Hold
839
– – ﹤0.01% 497
2013
Q4
$10K Hold
839
– – ﹤0.01% 485
2013
Q3
$10K Hold
839
– – ﹤0.01% 476
2013
Q2
$8K Buy
+839
New +$7.12K ﹤0.01% 488

Other funds holding BSX

Duncker Streett & Co's BSX Position: Q2 2021 in Review

Duncker Streett & Co sold out of Boston Scientific (BSX) in Q2 2021, closing a stake of 839 shares — an estimated $32K sold.

Duncker Streett & Co first reported a position in BSX in Q2 2013 and held it in 31 quarters. The position peaked at $38K in Q4 2019. 870 funds tracked by Wall St. Rank hold BSX as of Q2 2021.

  • Duncker Streett & Co reported no remaining Boston Scientific position as of Q2 2021 after selling out during the quarter.
  • Duncker Streett & Co sold 839 Boston Scientific shares in Q2 2021, an estimated $32K.
  • Duncker Streett & Co first reported a position in Boston Scientific in Q2 2013 and held it in 31 quarters.
  • Duncker Streett & Co's Boston Scientific position peaked at $38K in Q4 2019.
  • 870 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2021.

Based on Duncker Streett & Co's 13F filing for Q2 2021, filed 27 Jul 2021.